Ginkgo Bioworks teams with Carnegie Mellon on cancer detection program
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The company also reported significant progress toward its internally defined Sustainable Development Goals
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The initiative is focused on a problem that continues to plague cancer outcomes in India
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
Subscribe To Our Newsletter & Stay Updated